MedTech Terms
    The authoritative reference
    All terms
    Quality & RiskQuality System

    Biocompatibility

    Ability of a material to perform with an appropriate host response in a specific application.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Biocompatibility evaluates how a medical device material interacts with the human body to ensure it does not produce adverse biological responses such as cytotoxicity, sensitization, or systemic toxicity.
    What the regulation says
    Regulators like the FDA and notified bodies under the EU MDR emphasize biocompatibility as a critical aspect of patient safety. ISO 10993 series is the primary standard for evaluating the biological effects of medical devices, offering a framework for risk management in this area. Manufacturers must demonstrate that their devices do not pose unacceptable biological risks throughout their lifecycle, as outlined in requirements like EU MDR Annex I, Chapter I, Section 10.1.

    What this means in practice

    Tests are selected per ISO 10993-1 based on contact category and duration. Material changes typically trigger re-evaluation.

    Examples

    • A manufacturer of a new cardiovascular stent must conduct extensive biocompatibility testing, including hemocompatibility, due to its direct and prolonged contact with blood.
    • Before introducing a new adhesive in the assembly of a wound dressing, a company must re-evaluate the dressing's biocompatibility, focusing on potential skin sensitization and irritation.
    • An orthopedic implant manufacturer must assess the long-term biological response, including degradation product analysis, for their device due to its permanent implantation within the body.
    Common pitfalls
    • •Failing to consider the entire manufacturing process and all constituent materials when assessing biocompatibility is a common mistake.
    • •Assuming prior biocompatibility data for a material is sufficient without considering its processing or final device application can lead to non-compliance.
    • •Neglecting to re-evaluate biocompatibility after intended changes to material suppliers, manufacturing processes, or sterilization methods is a significant pitfall.
    • •Not adequately addressing extractables and leachables profiles can result in incomplete biocompatibility assessments.
    • •Ignoring the potential for long-term biological effects for permanently implanted devices is a serious oversight.

    Frequently asked questions

    The ISO 10993 series of standards, particularly ISO 10993-1, provides a comprehensive framework for biological evaluation of medical devices. It guides the selection of appropriate tests based on the nature and duration of device contact with the body.
    Grouped by theme

    Mentioned in recent activity

    1 entry

    Latest in MedTech

    View all

    Recent regulatory actions, publications, and trials matched to this term. Updated daily.

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    FDA·2ISO·1
    1. 1
      FDA Biocompatibility Guidance
      Verified
      FDAfda.gov
    2. 2
      FDA - Quality Systems
      Verified
      FDAfda.gov
    3. 3
      ISO 13485 Standard Page
      Verified
      ISOiso.org

    Inline markers like [1] jump to the matching reference above.